M Lowery

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. doi Genomics and pharmacogenomics of pancreatic adenocarcinoma
    M A Lowery
    Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Pharmacogenomics J 12:1-9. 2012
  2. ncbi Targeted therapies for pancreatic adenocarcinoma
    M Lowery
    Memorial Sloan Kettering Cancer Centre, Weill Medical College of Cornell University, Department of Medicine, GI Oncology ServiceNew York, NY, USA
    Minerva Chir 64:501-19. 2009
  3. doi A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma
    Maeve Lowery
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Gastrointest Cancer 42:160-4. 2011

Detail Information

Publications3

  1. doi Genomics and pharmacogenomics of pancreatic adenocarcinoma
    M A Lowery
    Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Pharmacogenomics J 12:1-9. 2012
    ....
  2. ncbi Targeted therapies for pancreatic adenocarcinoma
    M Lowery
    Memorial Sloan Kettering Cancer Centre, Weill Medical College of Cornell University, Department of Medicine, GI Oncology ServiceNew York, NY, USA
    Minerva Chir 64:501-19. 2009
    ..Herein the authors review the evidence to date for the use of novel cytotoxic and molecularly targeted agents in pancreatic adenocarcinoma, and discuss key areas for future therapeutic development...
  3. doi A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma
    Maeve Lowery
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Gastrointest Cancer 42:160-4. 2011
    ..Individuals who carry a germline mutation in the BRCA 1 or 2 genes have an increased lifetime risk of developing pancreatic adenocarcinoma when compared with the general population...